Company profile for Kamada

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins. AAT i...
Kamada Ltd. is focused on plasma-derived protein therapeutics for orphan indications, and has a commercial product portfolio and a robust late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins. AAT is a protein derived from human plasma with known and newly-discovered therapeutic roles given its immunomodulatory, anti-inflammatory, tissue-protective and antimicrobial properties.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Israel
Address
Address
HEAD OFFICE 2 Holzman St, Science Park, P.O Box 4081, Rehovot 7670402, Israel
Telephone
Telephone
+972 8 9406472
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/10/3184345/0/en/Kamada-Reports-Strong-Third-Quarter-and-Nine-Month-2025-Financial-Results-with-over-30-Year-over-Year-Profitability-Growth.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/10/29/3176285/0/en/Kamada-to-Present-at-the-Stifel-2025-Healthcare-Conference.html

GLOBENEWSWIRE
29 Oct 2025

https://www.globenewswire.com/news-release/2025/09/02/3142492/0/en/Kamada-to-Participate-in-Upcoming-September-Investor-Conferences.html

GLOBENEWSWIRE
02 Sep 2025

https://www.globenewswire.com/news-release/2025/08/13/3132448/0/en/Kamada-Reports-Strong-Second-Quarter-and-First-Half-2025-Financial-Results-with-11-Year-Over-Year-6-Month-Top-Line-Growth-and-a-35-Increase-in-Profitability-Raises-Full-Year-Profit.html

GLOBENEWSWIRE
13 Aug 2025

https://www.globenewswire.com/news-release/2025/08/11/3130769/0/en/Kamada-Announces-FDA-Approval-of-its-Plasma-Collection-Center-in-Houston-Texas.html

GLOBENEWSWIRE
11 Aug 2025

https://www.globenewswire.com/news-release/2025/08/06/3128174/0/en/Kamada-to-Announce-Second-Quarter-and-First-Half-Ended-June-30-2025-Financial-Results-on-August-13-2025.html

GLOBENEWSWIRE
06 Aug 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty